bpc 157 clinical trials safety human If BPC-157 worked as well as the internet says it does… …we'd probably have high quality by now. Instead we have... Lots of rat studies. Lots of podcasts. Lots of The Stable Gastric Pentadecapeptide BPC

Turn it upside down and slowly pull back the plunger to draw your calculated dose of TB 500 (e.g., 250 mcg)

Loading Phase (Weeks 1 through 4) Tb-500: 2 to 2.5 mg twice weekly (Monday and Thursday) totaling 4 to 5 mg per week Bpc-157: 0.5 mg daily, either as single dose or split into 0.25 mg twice daily Maintenance Phase (Weeks 5 through 8 plus) Tb-500: 2 mg once weekly Bpc-157: 0.25 to 0.5 mg daily Critical Notes Use separate vials and syringes for each peptide Never mix Bpc-157 and Tb-500 in the same syringe Tb-500 can be injected anywhere subcutaneously Bpc-157 should ideally be injected near the injury site The critical implementation detail bears repeating: Bpc-157 and Tb-500 should never be combined into a single vial as peptides lose their effectiveness when mixed incorrectly

This guide exists because that moment of uncertainty should never happen again

They are classified as research compounds, meaning they are not approved for human use in any form